EVLV Q4 2025: ARR Climbs 21% as Direct Fulfillment Model Drives Recurring Revenue Leverage

March 10, 2026 | By EarningsIQ Research

Evolve Technology’s Q4 marked a pivotal year-end with its recurring revenue engine gaining momentum, propelled by a strategic shift to direct fulfillment and robust customer expansion across core verticals. The company’s unique hardware-enabled SaaS model is deepening its competitive moat, while 2026 guidance signals accelerating ARR growth and expanded EBITDA margin. Investors should watch for continued leverage from operational scale, regulatory tailwinds, and the impact of healthcare and education mandates on long-term demand.

Summary

• Direct Fulfillment Shift Unlocks Recurring Upside: Evolve’s in-house subscription fulfillment is boosting revenue durability and future gross profit leverage.
• Multi-Segment Expansion Drives Customer Base: Balanced new logo and expansion wins highlight strong adoption in education, healthcare, workplaces, and sports venues.
• 2026 Outlook Signals Accelerating ARR and Margin: Raised guidance and regulatory tailwinds position Evolve for durable, high-visibility growth.

Performance Analysis

Evolve Technology delivered a robust Q4, closing 2025 with a 21% year-over-year increase in annual recurring revenue (ARR), underpinned by strong execution in both new customer acquisition and expansion among existing clients. The company’s top-line revenue growth was driven by its strategic transition to direct fulfillment of purchase subscriptions, which, while initially dilutive to gross margin percentage, is set to deliver higher gross profit dollars and greater revenue visibility over the contract lifecycle. This approach is reshaping the financial profile, as more value is captured in-house and translated into recurring performance obligations (RPO).

Adjusted EBITDA turned positive for the fifth consecutive quarter, with margin improvement reflecting the company’s focus on operational discipline and working capital efficiency. Cash and equivalents rose sequentially, demonstrating strong cash collections and disciplined working capital management, though management flagged that some Q4 cash flow benefits were non-repeatable. Segment performance was broad-based, with education, healthcare, sports and live entertainment, and workplace security all contributing meaningfully to growth. The Gen2 Express platform and the Expedite bag screening solution both saw increased adoption, signaling healthy product attach rates and deepening customer relationships.

• Gross Margin Dynamics: The shift to direct fulfillment and a one-time service cost accrual led to a temporary dip in gross margin percentage, but total gross profit dollars and future ARR are rising.
• Customer Base Expansion: 60 new customers added in Q4, with a balanced 50-50 mix of new and expanding accounts, and over 1,200 customers globally.
• Product Innovation Impact: Expedite adoption reached 65 customers, with multi-product sales driving higher customer lifetime value and lower acquisition costs.

Evolve’s operational leverage is beginning to materialize, as expense growth remains well below top-line expansion. The company’s backlog and RPO growth provide a strong foundation for 2026, with management signaling further acceleration in recurring revenue metrics as the new model matures.

Executive Commentary

Strategic Positioning

1. Hardware-Enabled SaaS Moat

Evolve’s vertically integrated model—combining proprietary hardware, AI-driven software, and exclusive data—creates a defensible competitive moat. This end-to-end control enables rapid model iteration and operational reliability, setting Evolve apart from pure SaaS competitors vulnerable to generative AI commoditization. The company’s approach translates into highly differentiated, real-world threat detection capabilities, underpinning long-term customer retention and recurring revenue growth.

2. Direct Fulfillment Model Transformation

The strategic pivot to in-house fulfillment of purchase subscriptions is reshaping the revenue mix. While this transition temporarily pressures gross margin percentage, it increases total revenue, ARR, and gross profit dollars over the contract’s life, enhancing the predictability and durability of Evolve’s financial model. This move also boosts RPO, providing greater visibility and future leverage as the installed base expands.

3. Multi-Vertical Demand and Regulatory Tailwinds

Education, healthcare, sports/entertainment, and workplace security all posted strong momentum, with new mandates in states like California and potential legislation in Georgia creating regulatory tailwinds for adoption. The American Hospital Association partnership further validates Evolve’s healthcare push, unlocking access to nearly 5,000 hospitals and driving vertical penetration.

4. Product Portfolio Expansion and Attach Rates

Expedite, Evolve’s AI-powered bag screening solution, is gaining traction both with new and existing customers. Multi-product sales are increasing customer acquisition efficiency and strengthening subscription stickiness, while Gen2 upgrades reinforce the company’s position as a technology leader in high-throughput environments.

5. Operational Leverage and Cost Discipline

Expense growth remains well below revenue expansion, with operational investments focused on R&D and sales while G&A efficiency is realized through insourcing and contractor reduction. Headcount is stable, with a shift from external consultants to in-house roles, supporting margin improvement without incremental spend.

Key Considerations

Evolve’s Q4 and full-year performance illustrate a business in transition—moving from rapid top-line growth to a more durable, recurring revenue model with operational leverage. The company’s strategic bets on direct fulfillment, product innovation, and multi-vertical expansion are beginning to yield measurable results, but execution and market adoption remain critical to sustaining momentum.

Key Considerations:

• ARR Acceleration Trajectory: Management expects ARR growth to outpace total revenue in 2026 as higher software and service pricing flows through the base and direct fulfillment scales.
• Regulatory Adoption Catalysts: State mandates and healthcare partnerships are providing structural demand drivers, particularly in education and hospital security.
• Gross Margin Recovery Path: Near-term margin dilution from model changes is expected to normalize as higher-margin recurring revenue ramps and Plexus manufacturing comes online in H2 2026.
• Cash Flow Sustainability: Q4’s cash performance was strong, but some one-time collections are not repeatable; focus is on achieving sustainable, positive cash flow in the second half of 2026.

Risks

Gross margin pressure from the fulfillment model transition, as well as potential volatility in hardware costs (notably memory chips), could weigh on near-term profitability. Regulatory adoption, while a tailwind, introduces timing uncertainty. Execution risk remains around scaling manufacturing with Plexus and maintaining operational discipline as growth accelerates. Customer concentration in core verticals and the pace of multi-product adoption also warrant close monitoring.

Forward Outlook

For Q1 2026, Evolve expects:

• Revenue growth rate in the high 30% range, driven by record backlog installation and one-time product revenue step-up.
• Modest sequential revenue decline in Q2 as backlog is consumed.

For full-year 2026, management raised guidance:

• Revenue of $172 million to $178 million (up from prior $160 to $165 million).
• ARR exit run-rate of $145 million to $150 million, representing 20% to 25% growth.
• Adjusted EBITDA margin expansion into the high single digits.

Management highlighted several factors that will shape the year:

• ARR growth is expected to accelerate through 2026 as higher-value contracts flow through the base.
• Plexus manufacturing partnership is on track for H2, providing gross margin and working capital tailwinds.

Takeaways

Evolve is demonstrating that its hardware-enabled SaaS model can deliver both growth and operational leverage, with recurring revenue and RPO building visibility into 2026 and beyond. The company’s direct fulfillment strategy is a double-edged sword in the short term—pressuring margins but driving higher-value, longer-term contracts. Expansion across education, healthcare, and enterprise verticals, combined with regulatory momentum, positions Evolve as a structural beneficiary of rising security needs.

• Recurring Revenue Engine: Direct fulfillment and multi-year subscriptions are increasing the durability and predictability of Evolve’s revenue base.
• Operational Leverage Materializing: Expense growth is lagging revenue, with cash flow and EBITDA margin both trending positively.
• Regulatory and Product Catalysts: Healthcare partnerships, state mandates, and product innovation (Expedite, Gen2) are expanding Evolve’s addressable market and deepening customer relationships.

Conclusion

Evolve Technology’s Q4 and 2025 results confirm the company’s successful pivot to a recurring, hardware-enabled SaaS model, with direct fulfillment and product innovation underpinning future growth. The raised 2026 outlook, combined with operational discipline and regulatory tailwinds, sets the stage for continued ARR acceleration and expanding profitability. Execution on manufacturing scale and sustained customer expansion will be key to maintaining this positive trajectory.

Industry Read-Through

Evolve’s results and strategic moves highlight a broader industry trend: physical security is rapidly shifting toward integrated, hardware-enabled SaaS models, with proprietary data and AI-driven analytics as key differentiators. Regulatory mandates in education and healthcare are likely to accelerate adoption across the sector, creating a rising tide for solution providers able to deliver end-to-end, scalable platforms. The pivot away from legacy distribution toward direct fulfillment and recurring revenue is a playbook that other hardware-heavy SaaS players may seek to emulate, particularly as investors increasingly favor durable, high-visibility business models. Companies exposed to education, healthcare, and critical infrastructure security should monitor regulatory developments and product innovation cycles closely, as these are set to shape the competitive landscape and margin structures for years to come.

EVLV Technology Security SaaS Recurring Revenue Hardware Education Healthcare